20 Small Cap Stocks Across 20 Sectors — A 5-Year Framework
$KULR
Advanced thermal management and battery systems for space, aerospace, AI data centers, and defense. Revenue grew 51% year-over-year in 2025 to $16M+. A five-year preferred battery supply agreement with Caban Energy was locked in January 2026. The company is also expanding into counter-UAS directed energy systems. Micro-cap with real government-grade technology and growing commercial contracts across critical infrastructure.
$BTBT
One of the world’s largest Ethereum treasury companies with $532M+ in ETH on its balance sheet. FY2025 revenue reached $113.6M as the company redirected capital from legacy bitcoin mining into ETH infrastructure and AI compute through its WhiteFiber subsidiary. Current ratio of 6.4x signals a surprisingly solid balance sheet for a crypto-adjacent name. Two analysts carry Strong Buy ratings with a $6 price target — nearly 3x from current levels around $1.52. Pure play on Ethereum + AI compute convergence.
$EVER
EverQuote runs an AI-powered insurance marketplace that connects consumers to carriers at scale. Revenue grew approximately 41% year-over-year in the first nine months of 2025, with the company targeting $1B+ in annual revenues long term. Carries a Zacks #1 Strong Buy rating with 2026 EPS estimates up 19% year-over-year. One of the few profitable growth names on this list — and one of the most overlooked AI-native fintech plays in the small-cap universe.
$HLIT
Harmonic builds the video delivery software and cable access infrastructure powering next-generation streaming and broadband networks. The company has delivered consecutive earnings beats, carries growing exposure to the AI live sports streaming TAM, and maintains a sticky enterprise customer base across major cable and telco operators. A steady compounder in an infrastructure layer most retail investors ignore entirely.
$RXRX
Recursion is building the operating system for AI-native drug discovery — using machine learning to decode biology at industrial scale. Backed by Roche-Genentech and Bayer, the company is advancing multiple clinical programs while building the world’s largest biological dataset. Pre-revenue in the traditional sense, but a platform-defining company that sits at the intersection of two of the most powerful forces in science: AI and pharmaceuticals.
$ADUR
Aduro’s proprietary Hydrochemolytic™ process converts waste plastics into valuable oils and fuels without combustion. The NGP pilot plant completed commissioning and moved to active operating campaigns in early 2026, while the Chemelot industrial site in the Netherlands was selected for the first-of-a-kind commercial facility. Cash position strengthened to CAD $39.4M after a U.S. offering. A commercial licensing MOU was signed in March 2026. Pre-revenue — but the plant is real, the process works, and the catalysts are building.
$GFAI
Guardforce AI deploys AI-powered security and surveillance robots across Asia-Pacific facilities, with expanding capabilities in facility management and autonomous monitoring. This is the highest-risk name on this list — ultra micro-cap with limited liquidity — but it sits at the convergence of physical AI and security automation, both of which are decade-long growth trends. Position sizing discipline is essential here.
$AEYE
AudioEye provides an AI-powered digital accessibility platform that helps businesses comply with ADA and WCAG regulations automatically. As global digital accessibility laws tighten across the U.S., EU, and beyond, the total addressable market expands without any additional sales effort needed. Recurring SaaS revenue model with improving unit economics, growing enterprise validation, and a regulatory tailwind that compounds every year.
